Hubei Biocause Pharmaceutical (000627) — Capital Reinvestment Ratio
Hubei Biocause Pharmaceutical (000627) has a Capital Reinvestment Ratio of 0.04x as of September 2023, meaning it reinvests 0% of its operating cash flow (CN¥276.06 Million) in capital expenditures (CN¥10.51 Million). See 000627 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hubei Biocause Pharmaceutical Capital Reinvestment Ratio (2001–2023)
This chart tracks Hubei Biocause Pharmaceutical's Capital Reinvestment Ratio across 16 annual periods. Check 000627 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hubei Biocause Pharmaceutical (2001–2023)
Year-by-year Capital Reinvestment Ratio for Hubei Biocause Pharmaceutical from 2001 to 2023. For live market cap and broader valuation context, see 000627 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | CN¥9.53 Billion | CN¥67.53 Million | ▼ -60.5% |
| 2022 | 0.02x | CN¥7.52 Billion | CN¥135.06 Million | ▼ -73.9% |
| 2021 | 0.07x | CN¥4.17 Billion | CN¥287.13 Million | ▲ +361.4% |
| 2020 | 0.01x | CN¥21.42 Billion | CN¥319.51 Million | ▼ -40.5% |
| 2019 | 0.03x | CN¥28.60 Billion | CN¥717.10 Million | ▲ +36.8% |
| 2018 | 0.02x | CN¥14.98 Billion | CN¥274.67 Million | ▼ -99.0% |
| 2017 | 1.80x | CN¥431.58 Million | CN¥778.95 Million | ▲ +63.8% |
| 2013 | 1.10x | CN¥130.53 Million | CN¥143.80 Million | ▼ -19.6% |
| 2012 | 1.37x | CN¥93.79 Million | CN¥128.50 Million | ▼ -38.6% |
| 2011 | 2.23x | CN¥66.95 Million | CN¥149.37 Million | ▲ +438.3% |
| 2010 | 0.41x | CN¥224.58 Million | CN¥93.09 Million | ▼ -24.1% |
| 2007 | 0.55x | CN¥118.56 Million | CN¥64.76 Million | ▼ -46.2% |
| 2006 | 1.02x | CN¥128.19 Million | CN¥130.12 Million | ▲ +101.5% |
| 2005 | 0.50x | CN¥48.66 Million | CN¥24.51 Million | ▲ +10.7% |
| 2004 | 0.46x | CN¥56.07 Million | CN¥25.52 Million | ▼ -46.0% |
| 2001 | 0.84x | CN¥37.30 Million | CN¥31.47 Million | — |